ESPI/EBI - komunikaty giełdowe

Change in shareholding structure of the Company

Completion of clinical trials for its epidural instrument

Completion of Enrollment in Clinical Trials for the Epidural Instrument

Conclusion of the agreement with an Authorised Adviser

Consolidated quarterly report for first quarter 2016

Information on a transaction concluded by a member of the Board of Directors

Change in shareholding structure of the Company

Consolidated Annual Report for year ended December 31, 2015

Withdrawal from the transmission of shares to regulated market of Warsaw Stock Exchange

Information on the date of the Annual Meeting of Shareholders